Evidence map›Paper›PMID 36309729›Full record

ArticleJournal of neuroinflammation2022

Coexistence of chronic hyperalgesia and multilevel neuroinflammatory responses after experimental SCI: a systematic approach to profiling neuropathic pain.

Lei Wang, Mehmet A Gunduz, Ana T Semeano, Enis C Yılmaz, Feras A H Alanazi, Ozan B Imir, Ulas Yener, Christian A Arbelaez, Esteban Usuga, Yang D Teng

Open access · goldAbstract read
In one paragraph

Article in Journal of neuroinflammation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 2 pooled it
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 2 syntheses or guidelines pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. SGK1 upregulation in GFAPCell death & disease · 2025
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Lei WangDepartment of Physical Medicine and Rehabilitation, Harvard Medical School, Boston, MA, USA.
Mehmet A GunduzDepartment of Physical Medicine and Rehabilitation, Harvard Medical School, Boston, MA, USA.
Ana T SemeanoDepartment of Physical Medicine and Rehabilitation, Harvard Medical School, Boston, MA, USA.
Enis C YılmazDepartment of Physical Medicine and Rehabilitation, Harvard Medical School, Boston, MA, USA.
Feras A H AlanaziDepartment of Physical Medicine and Rehabilitation, Harvard Medical School, Boston, MA, USA.
Ozan B ImirDepartment of Physical Medicine and Rehabilitation, Harvard Medical School, Boston, MA, USA.
Ulas YenerDepartment of Physical Medicine and Rehabilitation, Harvard Medical School, Boston, MA, USA.
Christian A ArbelaezDepartment of Physical Medicine and Rehabilitation, Harvard Medical School, Boston, MA, USA.
Esteban UsugaDepartment of Physical Medicine and Rehabilitation, Harvard Medical School, Boston, MA, USA.
Yang D TengDepartment of Physical Medicine and Rehabilitation, Harvard Medical School, Boston, MA, USA. yang_teng@hms.harvard.edu.
Harvard University · USMass General Brigham · USSpaulding Rehabilitation Hospital · US

Funding

The SCI Trust Fund of The Commonwealth of Massachusetts INTF3110HH2191525008The US AMRMC (SCIRP) W81XWH-15-1-0621
6 · The paper itself

Abstract

backgroundPeople with spinal cord injury (SCI) frequently develop neuropathic pain (NP) that worsens disability and diminishes rehabilitation efficacy. Chronic NP is presently incurable due to poor understanding of underlying mechanisms. We hypothesized that multilocus neuroinflammation (NIF) might be a driver of SCI NP, and tested it by investigating whether NP coexisted with central NIF, neurotransmission (NTM), neuromodulation (NML) and neuroplasticity (NPL) changes post-SCI.

methodsFemale Sprague-Dawley rats (230-250 g) with T10 compression or laminectomy were evaluated for physical conditions, coordinated hindlimb functions, neurological reflexes, and mechanical/thermal sensitivity thresholds at 1 day post-injury (p.i.) and weekly thereafter. Eight weeks p.i., central nervous system tissues were histochemically and immunohistochemically characterized for parameters/markers of histopathology and NIF/NTM/NML/NPL. Also analyzed was the correlative relationship between levels of selected biomarkers and thermosensitivity thresholds via statistical linear regression.

resultsSCI impaired sensorimotor functions, altered reflexes, and produced spontaneous pain signs and hypersensitivity to evoked nociceptive, mechanical, and thermal inputs. Only injured spinal cords exhibited neural lesion, microglia/astrocyte activation, and abnormal expression of proinflammatory cytokines, as well as NIF/NTM/NML/NPL markers. Brains of SCI animals displayed similar pathophysiological signs in the gracile and parabrachial nuclei (GrN and PBN: sensory relay), raphe magnus nucleus and periaqueduct gray (RMN and PAG: pain modulation), basolateral amygdala (BLA: emotional-affective dimension of pain), and hippocampus (HPC: memory/mood/neurogenesis). SCI augmented sensory NTM/NPL (GrN and PBN); increased GAD67 (PAG) level; reduced serotonin (RMN) and fear-off neuronal NTR2 (BLA) expressions; and perturbed neurogenesis (HPC).

conclusionT10 compression caused chronic hyperalgesia that coexisted with NIF/NTM/NML/NPL responses at multilevel neuroaxis centers. The data have provided multidimensional biomarkers as new mechanistic leads to profile SCI NP for therapeutic/therapy development.

Indexed as

NeuralgiaSpinal Cord InjuriesAnimalsBiomarkersFemaleHyperalgesiaInflammationRatsRats, Sprague-DawleyBiomarkersNeurogenesisNeuroinflammationNeuropathic painNeuroplasticityRatSpinal cord injury

Identifiers

PMID36309729
PMCPMC9617391
OpenAlexW4307951984

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.